LTR Pharma Limited (AU:LTP) has released an update.
LTR Pharma Limited has publicly released its Annual Financial Report and Preliminary Final Report, highlighting the company’s financial performance for the year ended June 30, 2024. The documents, which include a consolidated Financial Report and the Directors’ Report, are in compliance with ASX Listing Rule 4.2A. The announcement was made by Lee Rodne, the Executive Chairman of LTR Pharma Limited.
For further insights into AU:LTP stock, check out TipRanks’ Stock Analysis page.
